Airborne Purchased by GF Capital
Airborne Inc., maker of dietary supplements that support immune health, announces that it has been purchased by GF Capital Private Equity Fund, LP, a New York City-based private equity firm. Terms of the deal were not disclosed. Stockton Road Capital, LLC, advised and partnered with GF Capital with respect to this investment.
In addition, GF Capital names Martha (Marti) A. Morfitt as Airborne's new chief executive officer. Morfitt most recently served as chief executive officer and a director of CNS, Inc., a publicly traded marketer of consumer health care products. During her nine-year tenure, Morfitt and her team successfully completed a performance turnaround at CNS, returning the company to profitability and transforming it into a growing consumer health products company with flagship brands that include Breathe Right nasal strips and FiberChoice daily fiber supplement brands. CNS was sold to GlaxoSmithKline in December 2006.
In addition, GF Capital names Martha (Marti) A. Morfitt as Airborne's new chief executive officer. Morfitt most recently served as chief executive officer and a director of CNS, Inc., a publicly traded marketer of consumer health care products. During her nine-year tenure, Morfitt and her team successfully completed a performance turnaround at CNS, returning the company to profitability and transforming it into a growing consumer health products company with flagship brands that include Breathe Right nasal strips and FiberChoice daily fiber supplement brands. CNS was sold to GlaxoSmithKline in December 2006.
